V
Vyvanse
Productby Takeda Pharmaceutical Company
Heard in 5 episodes across 3 shows since Aug 2026
A prescription stimulant and prodrug of dextroamphetamine used primarily to treat ADHD and binge-eating disorder.
Discussed inHealth & Science100%
Episodes
5
across 3 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of Vyvanse per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 4 | 0.23‰ | 1 |
| Aug 7 | 0.16‰ | 1 |
| Aug 20 | 0.07‰ | 2 |
| Sep 21 | 0.03‰ | 1 |
| Oct 1 | 0.03‰ | 1 |
Episodes
5 episodes featuring Vyvanse, newest first
- Oct 1, 2026
Train focus with biology, structure, and deliberate recoveryHuberman Lab EssentialsOct 1, 2026 - Sep 21, 2026
Gut biology reshapes the fight against obesityHuberman Lab EssentialsSep 21, 2026 - Aug 20, 2026
ADHD disrupts regulation far beyond attentionThe Mel Robbins PodcastAug 20, 2026 - Aug 7, 2026
Hormonal transitions can expose ADHD’s hidden emotional costsunPAUSED with Dr. Mary Claire HaverAug 7, 2026 - Aug 4, 2026
Menopause can expose long-masked ADHD symptomsunPAUSED with Dr. Mary Claire HaverAug 4, 2026